FRI082 Impact Of Setmelanotide On Metabolic Parameters And Vital Signs In Patients With Hypothalamic Obesity

Disclosure: M.J. Abuzzahab: Advisory Board Member; Self; Pfizer, Inc., Endo Pharmaceuticals, Rhythm Pharmaceuticals, Inc., Consynance. Consulting Fee; Self; Pfizer, Inc., Endo Pharmaceuticals, Consynance, Rhythm Pharmaceuticals, Inc. A. Shoemaker: Advisory Board Member; Self; Rhythm Pharmaceuticals,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jennifer Abuzzahab, M, Shoemaker, Ashley, Gottschalk, Michael, Miller, Jennifer, Yuan, Guojun, Malhotra, Sonali, Scimia, Cecilia, Roth, Christian L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553489/
http://dx.doi.org/10.1210/jendso/bvad114.092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553489/
http://dx.doi.org/10.1210/jendso/bvad114.092

Ejemplares similares